Abstract:Objective: The protein arginine methyltransferase 5 (PRMT5) catalyzes the symmetrical bimethylation of arginine residues, which plays an important regulatory role in the life process. Transcription factor c-Myc is widely proved involved in the alteration and development of tumors, while the regulatory mechanism of c-Myc-mediated gene expression has not been fully understood. In this article we try to investigate the functional role of PRMT5 and c-Myc in regulating multiple myeloma cell proliferation. Methods: The protein and mRNA expression levels of PRMT5 in myeloma cells and normal cells were detected by Western Blot and qPCR. Lentivirally transduced shRNAs targeting PRMT5 (sh-PRMT5) was constructed using lentivirus mediated RNAi technology, and was packaged to infect MM cells to select positive colonies. The effect of PRMT5 on the proliferation of MM cells was detected by cck-8 assay. Annexin V/7-AAD double staining flow cytometry was used to detect cell survival and apoptosis rate. The expression of apoptotic suppressor gene c-Myc in sh-PRMT5 cell lines was detected by Western Blot and qPCR. Finally, double-knockdown of PRMT5 and c-myc was performed and gene expression differentiation were identified by RNA sequencing (RNA-seq). Results: PRMT5 expression in MM cell lines (RPMI8226 and U266) was relatively high compared with peripheral blood mononuclear cells (PBMCs), which was correlated with progression-free survival (PFS) and overall survival (OS) in MM patients. After sh-PRMT5 infection to MM cell lines, puromycin selection was performed and efficient gene knockdown was evaluated by Western Blot and qPCR. After targeted silencing of PRMT5 expression, the proliferation of MM cells was decreased and apoptosis was significantly increased (P < 0.05). C-Myc protein and mRNA levels were significantly downregulated after PRMT5 gene silencing. The results showed that PRMT5 promoted the proliferation of MM cells and inhibited the apoptosis of MM cells by regulating the expression of apoptotic suppressor gene c-Myc. Subsequently, RNA-seq confirmed SMCHD1 as the common candidate target gene of c-myc and PRMT5. Therefore, we speculated that PRMT5 and c-Myc may jointly regulate TNRC6B gene to promote the proliferation of MM cells. Conclusion: Altogether, our study not only proposed the mechanism PRMT5 and c-myc in regulating multiple myeloma related gene expression, but also provided a new strategy and theoretical basis for clinical treatment of multiple myeloma. Disclosures No relevant conflicts of interest to declare.

Targeting the Otub1/c-Maf Axis for the Treatment of Multiple Myeloma.

Targeting the Oncogenic Transcription Factor C-Maf for the Treatment of Multiple Myeloma.

The Ubiquitin-Conjugating Enzyme UBE2O Modulates C-Maf Stability and Induces Myeloma Cell Apoptosis

Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis

The Deubiquitinase USP7 Stabilizes Maf Proteins to Promote Myeloma Cell Survival

The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.

Halting Multiple Myeloma with MALT1 Inhibition: Suppressing BCMA-Induced NF-κB and Inducing Immunogenic Cell Death

Anti-bacterial and Anti-Viral Nanchangmycin Displays Anti-Myeloma Activity by Targeting Otub1 and C-Maf.

Inhibition of the Otub1/c-Maf Axis by the Herbal Acevaltrate Induces Myeloma Cell Apoptosis.

BMI1 Regulates Multiple Myeloma-Associated Macrophage’s Pro-Myeloma Functions

C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma

Dual Inhibition of Mtorc1/2 by DCZ0358 Induces Cytotoxicity in Multiple Myeloma and Overcomes the Protective Effect of the Bone Marrow Microenvironment

Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity

Inhibition of VCP Modulates NF-κB Signaling Pathway to Suppress Multiple Myeloma Cell Proliferation and Osteoclast Differentiation.

Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway

Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor C-Maf.

Transcription Factor C-Maf is a Checkpoint That Programs Macrophages in Lung Cancer.

Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation

C-Myc-Driven and PRMT5-Dependent Regulation of Multiple Myeloma Cell Proliferation Through TNRC6B Gene

Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma